Rodes Biopharma ApS: Financial statements 2025
CVR: 42425990
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Rodes Biopharma ApS (CVR 42425990) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,592,336 and a net result of DKK 1,503,450 compared with DKK 93,839 the year before. That is an increase of 215.3% compared with the year before. Equity in the 2025 report amounted to DKK 1,863,111. The solvency ratio was 75.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,592,336
- Profit/Loss
- DKK 1,503,450
- Equity
- DKK 1,863,111
- Total Assets
- DKK 2,462,029
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.6M | 1.5M | 1.9M | 2 |
| 2024 | - | 1.1M | 94K | 495K | 2 |
| 2023 | - | 1.8M | 387K | 523K | 1 |
| 2022 | - | 487K | 390K | 483K | 1 |
Official annual report
How creditworthy is Rodes Biopharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Rodes Biopharma ApS has published its annual report for 2024. Gross profit came to DKK 1,139,251, and the net result was DKK 93,839.
About Rodes Biopharma ApS
Rodes Biopharma ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Rodes ApS. The management consists of Jens Bo Rode Hansen. The board consists of Gitte Rode. The company is owned by Jens Bo Rode Hansen and Gitte Rode. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 3,592,336 and a net result of DKK 1,503,450 compared with DKK 93,839 the year before. Equity in the 2025 report amounted to DKK 1,863,111.